Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Sclerosis Transplant”

47 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 47 results

Testing effectiveness (Phase 2)Study completedNCT00342134
What this trial is testing

Immunological Mechanisms of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
National Institute of Neurological Disorders and Stroke (NINDS) 34
Testing effectiveness (Phase 2)UnknownNCT04150549
What this trial is testing

FMT for MS Patients

Who this might be right for
Multiple Sclerosis
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 34
Not applicableUnknownNCT02529839
What this trial is testing

Safety and Efficacy of an Immunoablative Nonmyeloablative Conditioning Protocol for Autologous Bone Marrow Transplantation (BMT) in Patients With Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis
Hadassah Medical Organization 20
Not applicableLooking for participantsNCT06195800
What this trial is testing

Biomarkers of aHSCT

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Sheffield Teaching Hospitals NHS Foundation Trust 15
Testing effectiveness (Phase 2)Ended earlyNCT01679041
What this trial is testing

High Dose Chemo With Stem Cell Transplant as Treatment for Multiple Sclerosis That Failed Prior Treatment

Who this might be right for
Multiple Sclerosis
Seah Lim M.D. 1
Testing effectiveness (Phase 2)WithdrawnNCT00497952
What this trial is testing

Allogeneic Stem Cell Transplantation for the Treatment of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Talaris Therapeutics Inc.
Not applicableStudy completedNCT02601131
What this trial is testing

Post-transfusion Platelet Count

Who this might be right for
LeukemiaMultiple Sclerosis
Region Skane 80
Testing effectiveness (Phase 2)Study completedNCT01099930
What this trial is testing

Autologous Stem Cell Transplant for Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Ottawa Hospital Research Institute 24
Not applicableUnknownNCT04674280
What this trial is testing

Observational Study in Multiple Sclerosis Patients Treated With Autologous Hematopoietic Stem Cell Transplantation

Who this might be right for
Multiple Sclerosis
European Society for Blood and Marrow Transplantation 50
Post-approval studies (Phase 4)Study completedNCT04952766
What this trial is testing

Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy Adults

Who this might be right for
Kidney TransplantMyelomaCancer+6 more
Centre Hospitalier Régional d'Orléans 196
Testing effectiveness (Phase 2)WithdrawnNCT05098145
What this trial is testing

A Safety and Efficacy Study of FCR001 in Adults With Rapidly Progressive Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Talaris Therapeutics Inc.
Not applicableNot Yet RecruitingNCT06228781
What this trial is testing

Autologous Hematopoietic Stem Cell Transplantation for Refractory Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Tianjin Medical University General Hospital 20
Not applicableStudy completedNCT04844489
What this trial is testing

Study of the Humoral Response to SARS-CoV-2 Variants and of the Cellular Response After Vaccination Against COVID-19 in Immunocompromised People

Who this might be right for
Autoimmune or Autoinflammatory DiseasesHIVMultiple Sclerosis+2 more
Assistance Publique - Hôpitaux de Paris 377
Not applicableNo Longer AvailableNCT02084121
What this trial is testing

Allogeneic Stem Cell Transplantation for the Treatment of Multiple Sclerosis (Compassionate Use)

Who this might be right for
Metachromatic Leukodystrophy
Talaris Therapeutics Inc.
Post-approval studies (Phase 4)Not Yet RecruitingNCT07240649
What this trial is testing

Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications

Who this might be right for
Post-COVID-19 ConditionUlcerative ColitisCrohn Disease+38 more
Jay C. Buckey Jr. 100
Early research (Phase 1)UnknownNCT03069170
What this trial is testing

Autologous Bone Marrow Derived Stem Cells for the Treatment of Multiple Sclerosis.

Who this might be right for
Multiple Sclerosis
Stem Cells Arabia 50
Not applicableLooking for participantsNCT06218927
What this trial is testing

The Effect of Autologous Hematopoietic Stem Cell Transplantation on the Lower Urinary Tract Function Related to QoL in MS Patients

Who this might be right for
Multiple SclerosisLower Urinary Tract Symptoms
University Hospital Ostrava 40
Large-scale testing (Phase 3)Ended earlyNCT03342638
What this trial is testing

Maximizing Outcome of Multiple Sclerosis Transplantation

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Northwestern University 66
Early research (Phase 1)Not Yet RecruitingNCT06900192
What this trial is testing

Allogeneic Hematopoietic Cell Transplantation for Primary Progressive Multiple Sclerosis

Who this might be right for
Primary Progressive Multiple SclerosisMultiple SclerosisMultiple Sclerosis, Primary Progressive+1 more
Stanford University 10
Testing effectiveness (Phase 2)Ended earlyNCT01228266
What this trial is testing

Mesenchymal Stem Cell Transplantation in MS

Who this might be right for
Multiple Sclerosis
Albert Saiz 9
Load More Results